Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.38M Sell
25,893
-1,333
-5% -$456K 0.67% 40
2026
Q1
$9.58M Buy
27,226
+272
+1% +$97K 0.79% 33
2025
Q4
$8.82M Buy
+26,954
New +$8.55M 0.7% 37

Other funds holding AMGN

MidFirst Bank's AMGN Position: Q2 2026 in Review

MidFirst Bank reduced its Amgen (AMGN) stake by 4.9% in Q2 2026, selling an estimated $456K and leaving 25,893 shares worth $9.38M. The position accounts for 0.67% of the portfolio, ranked #40.

MidFirst Bank first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.58M in Q1 2026. 2,737 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • MidFirst Bank held 25,893 shares of Amgen worth $9.38M as of Q2 2026.
  • MidFirst Bank sold 1,333 Amgen shares in Q2 2026, an estimated $456K.
  • Amgen made up 0.67% of MidFirst Bank's portfolio in Q2 2026, its #40 holding.
  • MidFirst Bank first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Amgen position peaked at $9.58M in Q1 2026.
  • 2,737 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.